BPG is committed to discovery and dissemination of knowledge
Observational Study
Copyright: ©Author(s) 2026. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution-NonCommercial (CC BY-NC 4.0) license. No commercial re-use. See permissions. Published by Baishideng Publishing Group Inc.
World J Psychiatry. Aug 19, 2026; 16(8): 117628
Published online Aug 19, 2026. doi: 10.5498/wjp.v16.i8.117628
Anxiety and depression symptoms correlate with metabolic indicators in metabolic dysfunction-associated steatotic liver disease patients
Zhen-Wei Wei, Xu-Dong Liu, Dong-Yang Li, Wan-Li Cheng, Yan-Ping Fu, Dan Yang
Zhen-Wei Wei, Wan-Li Cheng, Yan-Ping Fu, Dan Yang, Department of Hepatology and Gastroenterology Diagnosis and Treatment Center, The Fourth People’s Hospital of Nanning, Nanning 530023, Guangxi Zhuang Autonomous Region, China
Xu-Dong Liu, Department of Hepatology, Ruikang Hospital Affiliated to Guangxi University of Chinese Medicine, Nanning 530011, Guangxi Zhuang Autonomous Region, China
Dong-Yang Li, School of Nursing, Guangxi Medical University, Nanning 530021, Guangxi Zhuang Autonomous Region, China
Co-corresponding authors: Zhen-Wei Wei and Dong-Yang Li.
Author contributions: Wei ZW and Liu XD were responsible for the study conception and design, data collection and analysis, and drafting of the manuscript; Li DY provided critical supervision throughout the research process and contributed to the interpretation of results; Cheng WL participated in patient recruitment, questionnaire administration, and data verification; Fu YP assisted with laboratory specimen collection and metabolic indicator testing; Yang D contributed to imaging data acquisition and quality control procedures. All authors critically reviewed and revised the manuscript, approved the final version for submission, and agree to be accountable for all aspects of the work. We respectfully request approval for Li DY (School of Nursing, Guangxi Medical University) to serve as co-corresponding author alongside Wei ZW for the following reasons: (1) Complementary institutional expertise and independent oversight This study was conducted across two institutions. Wei ZW led clinical data collection at The Fourth People’s Hospital of Nanning, while Li DY provided independent methodological supervision from Guangxi Medical University. The involvement of two corresponding authors from distinct institutions ensures dual accountability and reflects the genuinely collaborative, cross-institutional nature of this research; (2) Substantial and indispensable intellectual contributions Li DY made critical contributions beyond supervisory oversight: She was centrally involved in the overall study design, directed the statistical analysis framework, and played a primary role in interpreting the correlation and regression findings that constitute the core results of this manuscript. These contributions are substantive and non-duplicative of those made by Wei ZW; (3) Responsibility for ongoing correspondence Given that Li DY is based at an academic institution with dedicated research infrastructure, she is well positioned to handle post-publication correspondence, data sharing requests, and future collaborative inquiries related to this work. Wei ZW, as the clinical lead, will remain the primary contact for clinical and patient-related queries; and (4) Alignment with established practice co-corresponding authorship is well-recognized in cross-disciplinary studies involving both clinical and academic research teams. The distinct and complementary roles of Wei ZW (clinical lead) and Li DY (methodological and academic lead) justify shared corresponding authorship, as each is uniquely accountable for different aspects of the work.
AI contribution statement: This work has been partially assisted by AI. Specifically, language polishing, grammar correction, and stylistic refinement were carried out with the support of AI tools. All data, figures, images, charts, tables, and original content presented in this work were created, collected, or generated by the authors and are not AI-generated.
Institutional review board statement: This study was reviewed and approved by the Ethics Committee of The Fourth People’s Hospital of Nanning, Approval No. 2025147. All procedures performed in this study were in accordance with the ethical standards of the institutional research committee and with the Declaration of Helsinki.
Informed consent statement: This study was observational in nature and involved only the use of anonymized routinely collected clinical data and questionnaire information, without any additional intervention. The Ethics Committee of The Fourth People’s Hospital of Nanning approved a waiver of informed consent, as the study posed no more than minimal risk to participants and obtaining individual informed consent was impracticable.
Conflict-of-interest statement: All authors declare that they have no conflict of interest related to this study.
STROBE statement: The authors have read the STROBE Statement-checklist of items, and the manuscript was prepared and revised according to the STROBE Statement-checklist of items.
Data sharing statement: The datasets generated and analyzed during the current study are available from the corresponding author upon reasonable request.
Corresponding author: Zhen-Wei Wei, Department of Hepatology and Gastroenterology Diagnosis and Treatment Center, The Fourth People’s Hospital of Nanning, No. 1 Changgang Road Erli, Xingning District, Nanning 530023, Guangxi Zhuang Autonomous Region, China. weizw@126.com
Received: January 13, 2026
Revised: February 11, 2026
Accepted: April 13, 2026
Published online: August 19, 2026
Processing time: 190 Days and 13.6 Hours
Core Tip

Core Tip: This cross-sectional study systematically assesses anxiety and depression symptoms alongside comprehensive metabolic indicators in patients with metabolic dysfunction-associated steatotic liver disease (MASLD). We found high rates of psychological symptoms that are significantly associated with key metabolic parameters including body mass index, triglycerides, liver fat content, and liver enzymes. These findings support a multidimensional relationship between mental health and metabolic dysfunction in MASLD and highlight the importance of integrating psychological screening and metabolic management in clinical care to improve overall outcomes. This work provides a basis for more holistic strategies in MASLD patient management.

Write to the Help Desk